株式会社京都創薬研究所
Kyoto, JP · 2 known investors
Kyoto Drug develops novel therapeutic drugs for rare and difficult-to-treat ocular diseases including retinal artery occlusion and retinitis pigmentosa, using a new small-molecule compound (KUS agent) based on research from Kyoto University.
Founders & leadership
M(
Musashi (武蔵)CEO
Investors · 2
Frequently asked questions
- What does 株式会社京都創薬研究所 do?
- Kyoto Drug develops novel therapeutic drugs for rare and difficult-to-treat ocular diseases including retinal artery occlusion and retinitis pigmentosa, using a new small-molecule compound (KUS agent) based on research from Kyoto University.
- Who are 株式会社京都創薬研究所's investors?
- 株式会社京都創薬研究所's investors include Kyoto University Innovation Capital, Miyako Capital.
- Where is 株式会社京都創薬研究所 headquartered?
- 株式会社京都創薬研究所 is headquartered in Kyoto, JP.